Breast Cancer Patients with the Breast Cancer Susceptibility Gene Are Poor Candidates for Some Chemotherapy Drugs
Researchers at Jefferson Medical College have found that alterations in a breast cancer susceptibility gene can change the effectiveness of certain chemotherapy drugs against the disease. The work highlights the new field of pharmacogenomic therapy, which has become increasingly important with the sequencing of the human genome and, it is hoped, will lead to improved cancer therapies.
Media Only Contact: Steven Benowitz Thomas Jefferson University Hospital
Message posted by: Wouter Kalle